Background: several lines of evidence show that abdominal fat is strongly associated with insulin resistance and dysglycemia (impaired glucose tolerance - igt or type 2 diabetes mellitus - t2dm). however, which component of abdominal fat, subcutaneous or intra-abdominal, has a major impact on the development of insulin resistance and dysglycemia is still a matter of debate. the aim of this review is to summarize the best available evidence on the contribution of subcutaneous and/or intra-abdominal adipose tissues to the incidence of impaired glucose tolerance and/or type 2 diabetes mellitus, in adults as well as to determine which type of abdominal fat is a better predictor of these metabolic disorders. methods: a search of published articl...
Background&Aims: Abdominal fat accumulation (Visceral/hepatic) has been associated with hepatic insu...
Abdominal Subcutaneous and Visceral Adipose Thickness Are Independently Associated with Insulin Resi...
To evaluate the relative impact of abdominal obesity and newly diagnosed type 2 diabetes on insulin ...
Abstract Background Previous studies have documented that visceral adipose tissue is positively asso...
Excess fat in the abdomen can be classified generally as visceral and subcutaneous adiposity. Eviden...
BACKGROUND: Abdominal obesity is a well-established risk factor for the development of type 2 diabet...
OBJECTIVE: Insulin resistance and type 2 diabetes are associated with an atherogenic lipoprotein pro...
OBJECTIVE — Obesity is associated with increased metabolic and cardiovascular risk. The ectopic fat ...
OBJECTIVE — Visceral obesity is shown to be a predictor of morbidity and mortality. We evaluated the...
Purpose. We aimed to assess the relationship between the regional body fat distribution and insulin ...
The burden of obesity has increased globally over the last few decades and its association with ins...
The association between abdominal fat accumulation and risk of chronic diseases, including type II d...
OBJECTIVE: Both visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) have been linked...
Aims: We investigated whether low subcutaneous thigh fat is an independent risk factor for unfavoura...
It is well known that visceral adipose tissue (VAT) is associated with insulin resistance (IR). Cons...
Background&Aims: Abdominal fat accumulation (Visceral/hepatic) has been associated with hepatic insu...
Abdominal Subcutaneous and Visceral Adipose Thickness Are Independently Associated with Insulin Resi...
To evaluate the relative impact of abdominal obesity and newly diagnosed type 2 diabetes on insulin ...
Abstract Background Previous studies have documented that visceral adipose tissue is positively asso...
Excess fat in the abdomen can be classified generally as visceral and subcutaneous adiposity. Eviden...
BACKGROUND: Abdominal obesity is a well-established risk factor for the development of type 2 diabet...
OBJECTIVE: Insulin resistance and type 2 diabetes are associated with an atherogenic lipoprotein pro...
OBJECTIVE — Obesity is associated with increased metabolic and cardiovascular risk. The ectopic fat ...
OBJECTIVE — Visceral obesity is shown to be a predictor of morbidity and mortality. We evaluated the...
Purpose. We aimed to assess the relationship between the regional body fat distribution and insulin ...
The burden of obesity has increased globally over the last few decades and its association with ins...
The association between abdominal fat accumulation and risk of chronic diseases, including type II d...
OBJECTIVE: Both visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) have been linked...
Aims: We investigated whether low subcutaneous thigh fat is an independent risk factor for unfavoura...
It is well known that visceral adipose tissue (VAT) is associated with insulin resistance (IR). Cons...
Background&Aims: Abdominal fat accumulation (Visceral/hepatic) has been associated with hepatic insu...
Abdominal Subcutaneous and Visceral Adipose Thickness Are Independently Associated with Insulin Resi...
To evaluate the relative impact of abdominal obesity and newly diagnosed type 2 diabetes on insulin ...